QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial-Reference-Cited by-同舟云学术

QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial

Published:2024 Issue: Volume:35 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Fang Cheng¹^ORCID,Zhou Yun¹^ORCID,Feng Yanling¹^ORCID,He Liping²^ORCID,Yu Jinjin³^ORCID,Li Yuzhi⁴^ORCID,Feng Mei⁵^ORCID,Pan Mei⁶^ORCID,Zhao Lina⁷^ORCID,Tang Dihong⁸^ORCID,Li Xiumin⁹^ORCID,Tan Buzhen¹⁰^ORCID,An Ruifang¹¹^ORCID,Zheng Xiaohui¹²^ORCID,Si Meimei¹²^ORCID,Zhang Baihui¹²^ORCID,Li Lingyan¹²^ORCID,Kang Xiaoyan¹²^ORCID,Zhou Qi¹³^ORCID,Liu Jihong¹^ORCID

Affiliation:

1. Department of Gynecological Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.

2. Department of Gynecological Oncology Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China.

3. Department of Gynecology, Affiliated Hospital of Jiangnan University, Wuxi, China.

4. Department of Gynecologic Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

5. Department of Gynecological Radiation Oncology, Fujian Cancer Hospital, Fuzhou, China.

6. Department of Medical Oncology, Jiangxi Maternal and Child Health Care Hospital, Nanchang, China.

7. Department of Radiotherapy, The First Affiliated Hospital of Air Force Medical University, Xi'an, China.

8. Gynecological Oncology Department IV, Hunan Cancer Hospital, Changsha, China.

9. Department of Gynecology, Linyi Cancer Hospital, Linyi, China.

10. Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

11. Department of Gynecology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

12. Qilu Pharmaceutical Co., Ltd., Jinan, China.

13. Gynecological Oncology Center, Chongqing University Cancer Hospital, Chongqing, China.

Funder

Qilu Pharmaceutical Co., Ltd

Publisher

XMLink

Link

https://ejgo.org/pdf/10.3802/jgo.2024.35.e77

Reference24 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Cancer Stat Facts. Cervical cancer [Internet]. Bethesda, MD. National Cancer Institute. 2023. cited 2023 Sep 3. Available from: https://seer.cancer.gov/statfacts/html/cervix.html

3. NCCN Guidelines Insights: Cervical Cancer, Version 1.2020

4. Mechanisms Used by Human Papillomaviruses to Escape the Host Immune Response

5. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors